Tricuspid and mitral endocarditis due to methicillin-resistant Staphylococcus aureus exhibiting vancomycin-creep

Pranathi Rao Sundaragiri1, Saraschandra Vallabhajosyula2, Toufik Mahfood Haddad3

  • 1Division of Hospital Internal Medicine, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

BMJ Case Reports
|November 5, 2015
PubMed

Insights

Right-sided infective endocarditis (RIE) caused by Staphylococcus aureus can be severe. Vancomycin-creep in MRSA indicates a poor prognosis, requiring aggressive treatment like daptomycin and ceftaroline.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Critical Care Medicine

Background:

  • Right-sided infective endocarditis (RIE) commonly involves Staphylococcus aureus and the tricuspid valve (TV).
  • Intravenous drug use is a significant risk factor for RIE.
  • Limited guidelines exist for surgical intervention in RIE, often extrapolated from left-sided disease.

Observation:

  • A 31-year-old male with a history of intravenous drug use presented with symptoms of RIE, including fever, dyspnea, and right-heart failure.
  • Laboratory findings revealed methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with lactic acidosis.
  • Echocardiography showed multiple vegetations on the tricuspid valve, and chest imaging confirmed septic emboli.

Findings:

  • The MRSA isolate exhibited 'vancomycin-creep,' a phenomenon associated with reduced vancomycin susceptibility.
  • Despite treatment with daptomycin and ceftaroline, the patient experienced persistent bacteremia and septic shock.
  • Surgical intervention for the tricuspid valve did not improve the patient's outcome, leading to death.

Implications:

  • Vancomycin-creep in MRSA-RIE portends a poorer prognosis and necessitates aggressive therapeutic strategies.
  • Ceftaroline salvage therapy in combination with daptomycin may be a viable option for refractory MRSA-RIE.
  • Further clinical trials are needed to establish optimal treatment guidelines for complex RIE cases, particularly those involving vancomycin-creep.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
99
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
33
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
760
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
330
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
782
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
463